Serum paraoxonase activity and phenotype distribution in Turkish subjects with coronary heart disease and its relationship to serum lipids and lipoproteins
A. Karakaya et al., Serum paraoxonase activity and phenotype distribution in Turkish subjects with coronary heart disease and its relationship to serum lipids and lipoproteins, CHEM-BIO IN, 118(3), 1999, pp. 193-200
Recently, biochemical studies of paraoxonase in the serum of humans have sh
own that much of this enzymes' activity is associated with high-density lip
oprotein (HDL) and paraoxonase may play a role in lipid metabolism preventi
ng the accumulation of the lipoperoxides. In this study, a possible relatio
nship between coronary heart disease (CHD) and paraoxonase activity were in
vestigated. Serum triglycerides, total cholesterol, HDL-cholesterol and par
aoxonase activity were measured in unrelated healthy donors and CHD patient
s. It was found that paraoxonase activity was trimodally distributed in bot
h groups but no statistically significant difference was found between phen
otype distributions of controls and CHD patients (gene frequencies; 0.632 a
nd 0.382 of controls, 0.702 and 0.298 of patients for the A and B alleles,
respectively). However, in CHD group, a high possibility was found to be ph
enotype A compared with the control group. A relative risk of 1.48 (95% con
fidence intervals (CI)? 0.986-2.227) was found for the relation between CHD
and the paraoxonase activity. Patients' HDL-cholesterol values were lower
and triglycerides were higher than controls (P < 0.001). It may be conclude
d from the present study that although no statistically significant differe
nce was found between paraoxonase phenotype distributions of controls and C
HD patients, a decrease in paraoxonase activity could become a risk factor
for this disease. (C) 1999 Elsevier Science Ireland Ltd. All rights reserve
d.